PRIA Healthcare News and Insights

March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies. His
PRIA a strategic and execution partner for reimbursement and market access
By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's H2 Newsletter - PRIA Pages
By Nancy Bax December 23, 2025
PRIA's Second Quarter in Review
PRIA is proud to support LSI in 2026
By Nancy Bax November 6, 2025
Continuing and Strengthening our Relationship with a Vital Industry Event
PRIA helps clients navigate the challenging MedTech market access landscape
By Nancy Bax October 21, 2025
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide
Behind the Strategy - An Expert's Perspective by Tonya Dowd, PRIA
By Tonya Dowd, MPH, EVP of RHEMA and Corporate Development August 5, 2025
US Reimbursement Policy in Flux
By PRIA Healthcare August 1, 2025
Prior Authorization is Coming to Fee-for-Service Medicare -- What You Need to Know About CMS's Proposed WISeR Model -- a webinar from PRIA Healthcare
By Tracy Davis July 21, 2025
Why KOL Engagement is Crucial for Market Access By Tracy Davis MS, RD, Director of Market Access
PRIA Pages - Quarterly Newsletter
July 17, 2025
In this issue of PRIA Pages, read about all that the PRIA team was up to in the MedTech industry in Q2, including LSI Asia, LSX, & Medtech Strategist's Innovation Summit!
MedTech Market Access Strategy
By Ryan Nolan May 6, 2025
A common pitfall that many MedTech entrepreneurs with promising technologies fall into is an assumption that if they build a superior product, customers will come.
More Posts